27 March 2020 : Case report
Immunosuppression and Malignant Neoplasms: Risk-Benefit Assessment in Patients with Inflammatory Bowel Disease
Adverse events of drug therapy, Clinical situation which can not be reproduced for ethical reasons
DOI: 10.12659/AJCR.920949
Am J Case Rep 2020; 21:e920949
HTML version available soon